Traumatic respiratory failure and veno-venous extracorporeal membrane oxygenation support.


Journal

Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 1 5 2021
medline: 22 6 2022
entrez: 30 4 2021
Statut: ppublish

Résumé

Respiratory failure (RF) is a common cause of death and morbid complication in trauma patients. Extracorporeal membrane oxygenation (ECMO) is increasingly used in adults with RF refractory to invasive mechanical ventilation. However, use of ECMO remains limited for this patient population as they often have contraindications for anticoagulation. Medical records were retroactively searched for all adult patients who were admitted to the trauma service and received veno-venous ECMO (VV ECMO) support between June 2015 and August 2018. Survival to discharge and ECMO-related complications were collected and analyzed. Fifteen patients from a large Level I trauma center met the criteria. The median PaO Survival rates of trauma patients in this study are equivalent to, or may exceed, those of non-trauma patients who receive ECMO support for other types of RF. With the employment of a multidisciplinary team assessment and proper patient selection, early cannulation, traumatic RF may be safely supported with VV ECMO in experienced centers.

Sections du résumé

BACKGROUND
Respiratory failure (RF) is a common cause of death and morbid complication in trauma patients. Extracorporeal membrane oxygenation (ECMO) is increasingly used in adults with RF refractory to invasive mechanical ventilation. However, use of ECMO remains limited for this patient population as they often have contraindications for anticoagulation.
STUDY DESIGN
Medical records were retroactively searched for all adult patients who were admitted to the trauma service and received veno-venous ECMO (VV ECMO) support between June 2015 and August 2018. Survival to discharge and ECMO-related complications were collected and analyzed.
RESULTS
Fifteen patients from a large Level I trauma center met the criteria. The median PaO
CONCLUSIONS
Survival rates of trauma patients in this study are equivalent to, or may exceed, those of non-trauma patients who receive ECMO support for other types of RF. With the employment of a multidisciplinary team assessment and proper patient selection, early cannulation, traumatic RF may be safely supported with VV ECMO in experienced centers.

Identifiants

pubmed: 33926332
doi: 10.1177/02676591211012840
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

477-483

Auteurs

Ismael A Salas De Armas (IA)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

Bindu Akkanti (B)

Division of Pulmonary, Critical Care and Sleep Medicine, UTHealth, Houston, TX, USA.

Pratik B Doshi (PB)

Division of Pulmonary, Critical Care and Sleep Medicine, UTHealth, Houston, TX, USA.
Department of Emergency Medicine, UTHealth, Houston, TX, USA.

Manish Patel (M)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

Sachin Kumar (S)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

M Hakan Akay (MH)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

Rahat Hussain (R)

Division of Pulmonary, Critical Care and Sleep Medicine, UTHealth, Houston, TX, USA.

Kha Dinh (K)

Division of Pulmonary, Critical Care and Sleep Medicine, UTHealth, Houston, TX, USA.

Muhammad Yasir Baloch (MY)

Division of Pulmonary, Critical Care and Sleep Medicine, UTHealth, Houston, TX, USA.

Mahmoud Samy Ahmed (MS)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

Igor Banjac (I)

Department of Emergency Medicine, UTHealth, Houston, TX, USA.

Marwan F Jumean (MF)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

Kelly McGinness (K)

Cardiovascular Perfusion Program, UTHealth, Houston, TX, USA.

Lisa M Janowiak (LM)

Department of Emergency Medicine, UTHealth, Houston, TX, USA.

Kriti Mittal Agrawal (K)

Department of General Surgery, UTHealth, Houston, TX, USA.

Sriram Nathan (S)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

John Zaki (J)

Department of Anesthesia, UTHealth, Houston, TX, USA.

Luis Nieto (L)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

Kimberly Klein (K)

Department of Pathology and Laboratory Medicine, UTHealth, Houston, TX, USA.

Ethan Taub (E)

Division of Acute Care Surgery, Trauma & Critical Care, UTHealth, Houston, TX, USA.

Hlaing Tint (H)

Department of Pathology and Laboratory Medicine, UTHealth, Houston, TX, USA.

Jayeshkumar A Patel (JA)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

Angelo Nascimbene (A)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

Biswajit Kar (B)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

Igor D Gregoric (ID)

Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH